Lobbying

Alliance for Patient Access's latest lobbying report covers Q2 2026, at $20K. The four quarters Q3 2025–Q2 2026 total $80K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Alliance for Patient Access

Latest quarter
$20K
Q2 2026 · 1 reports
Last 12 months
$80K
Last 4 quarters
vs last quarter
0.0%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Alliance for Patient Access lobbying by quarter
Alliance for Patient Access lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$20K1
Q2 2026$20K1

Policy issues the reports name

  • Health issues15 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
In-houseAlliance for Patient Access$300K15 quarters

Former officials lobbying for it

Former position
GAVIN CLINGHAMLegislative Director - Office of Alan MollohanQ2 2026

Lobbying reports

Filed by
07/20for Q2In-house$20K
04/20for Q1In-house$20K
01/19for Q4 2025In-house$20K
25/10/22for Q3 2025In-house$20K
25/07/23for Q2 2025In-house$20K
25/04/18for Q1 2025In-house$20K
25/01/21for Q4 2024In-house$20K
24/10/21for Q3 2024In-house$20K
24/07/22for Q2 2024In-house$20K
24/04/22for Q1 2024In-house$20K
24/01/24for Q4 2023In-house$20K
23/10/23for Q3 2023In-house$20K
23/07/26for Q2 2023In-house$20K
23/04/20for Q1 2023In-house$20K
23/01/20for Q4 2022In-house$20K